Christian Hebenstreit

COO, Rensair

Christian Hebenstreit is a highly experienced and accomplished technology and biotech executive, board advisor, and investor. His expertise lies in go-to-market strategies, product management, innovation development, as well as operational excellence. Most recently, Christian was the chief operating officer at Rensair, a world-leading pioneer in indoor air quality. He is an investor in biotx.ai, an AI-enabled biotech company that has created a platform capable of predicting the efficacy and side effects of new treatments, where he also served as COO. Before joining biotx.ai in 2020, Christian led Medidata’s European and Middle Eastern operations. Medidata, being one of the largest providers of clinical trial software used by major pharma companies, was acquired for $5.8B in 2019 by Dassault Systèmes.

Prior to his tenure at Medidata, Christian worked with Salesforce, where he served as VP across multiple large industry verticals, including the life sciences sector, amongst others. He holds a master’s in economics from the University of Muenster and successfully completed executive programs at IMD in Lausanne and the Massachusetts Institute of Technology.